Literature DB >> 7585665

Xenon CT measurement of cerebral blood flow in hydrocephalus.

P Maeder1, N de Tribolet.   

Abstract

Since the recognition of normal-pressure hydrocephalus as an entity (1965), ventriculo-atrial or peritoneal shunting has been proposed as a treatment for this disease. Unfortunately, selection of patients who would benefit from shunting has always been difficult, and no clinical or brain imaging criteria have been entirely satisfactory. Functional studies intended to measure the local cerebral blood flow (lCBF) seem more promising. Xenon CT CBF measurement has been chosen because of its ability to measure deep white matter lCBF with good spatial resolution. This preliminary study reports the results of lCBF measurement in four patients examined by this technique before and after shunting or cerebrospinal fluid subtraction by lumbar puncture. In this small collective the two patients who improved clinically after shunting or lumbar puncture also had a substantial improvement in deep white matter lCBF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585665     DOI: 10.1007/BF00717402

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  17 in total

1.  SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME.

Authors:  R D ADAMS; C M FISHER; S HAKIM; R G OJEMANN; W H SWEET
Journal:  N Engl J Med       Date:  1965-07-15       Impact factor: 91.245

2.  CBF measured by Xe-CT: approach to analysis and normal values.

Authors:  H Yonas; J M Darby; E C Marks; S R Durham; C Maxwell
Journal:  J Cereb Blood Flow Metab       Date:  1991-09       Impact factor: 6.200

3.  Leukoencephalopathy in normal and pathologic aging: 1. CT of brain lucencies.

Authors:  A E George; M J de Leon; C I Gentes; J Miller; E London; G N Budzilovich; S Ferris; N Chase
Journal:  AJNR Am J Neuroradiol       Date:  1986 Jul-Aug       Impact factor: 3.825

4.  Xenon enhanced CT for analysis of cerebral integrity, perfusion, and blood flow.

Authors:  B P Drayer; S K Wolfson; O M Reinmuth; M Dujovny; M Boehnke; E E Cook
Journal:  Stroke       Date:  1978 Mar-Apr       Impact factor: 7.914

5.  Pre- and postoperative evaluation of cerebral blood flow in low-pressure hydrocephalus.

Authors:  T V Greitz; A O Grepe; M S Kalmér; J Lopez
Journal:  J Neurosurg       Date:  1969-12       Impact factor: 5.115

6.  Pathogenesis of normal-pressure hydrocephalus--preliminary observations.

Authors:  J S Meyer; Y Kitagawa; N Tanahashi; H Tachibana; P Kandula; D A Cech; J E Rose; R G Grossman
Journal:  Surg Neurol       Date:  1985-02

7.  Computed tomographic measurement of the xenon brain-blood partition coefficient and implications for regional cerebral blood flow: a preliminary report.

Authors:  F Kelcz; S K Hilal; P Hartwell; P M Joseph
Journal:  Radiology       Date:  1978-05       Impact factor: 11.105

8.  Studies on cerebral oxygen metabolism, blood flow, and blood volume, in patients with hydrocephalus before and after surgical decompression, using positron emission tomography.

Authors:  D J Brooks; R P Beaney; M Powell; K L Leenders; H A Crockard; D G Thomas; J Marshall; T Jones
Journal:  Brain       Date:  1986-08       Impact factor: 13.501

9.  Cerebral blood flow in patients with normal-pressure hydrocephalus before and after shunting.

Authors:  S Vorstrup; J Christensen; F Gjerris; P S Sørensen; A M Thomsen; O B Paulson
Journal:  J Neurosurg       Date:  1987-03       Impact factor: 5.115

10.  Xenon inhalation as an adjunct to computerized tomography of the brain: preliminary study.

Authors:  S S Winkler; J F Sackett; J E Holden; D C Flemming; S C Alexander; M Madsen; R I Kimmel
Journal:  Invest Radiol       Date:  1977 Jan-Feb       Impact factor: 6.016

View more
  1 in total

1.  Xenon-enhanced cerebral blood flow at 28% xenon provides uniquely safe access to quantitative, clinically useful cerebral blood flow information: a multicenter study.

Authors:  A P Carlson; A M Brown; E Zager; K Uchino; M P Marks; C Robertson; G P Sinson; A Marmarou; H Yonas
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-23       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.